• 25-Hydroxycholesterol Drives Immunosuppressive TAM Reprogram

  2026-07-03

  Xiao et al. (2024) elucidate how 25-hydroxycholesterol accumulation in tumor-associated macrophages (TAMs) modulates lysosomal AMPK activation and STAT6 phosphorylation, reinforcing immunosuppressive phenotypes. This immunometabolic pathway positions CH25H as a target to improve anti-tumor immunity and responses to checkpoint blockade.

• Annexin V-FITC/7-AAD Apoptosis Kit: Technical Application Gu

  2026-07-03

  The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid and reliable method for distinguishing apoptotic from necrotic cells in cultured samples, supporting rigorous cell death analysis in research settings. It is best suited for flow cytometry and fluorescence microscopy-based cell viability and cytotoxicity assays, but is not intended for mechanistic pathway elucidation or use with unconventional specimens. Proper handling and protocol adherence are essential for reproducible results.

• Decitabine Enhances Anti–PD-1 Efficacy via CD8+ T Cell Repro

  2026-07-02

  This study demonstrates that low-dose decitabine primes CD8+ progenitor exhausted T cells, amplifying their expansion and cytolytic function in combination with anti–PD-1 therapy. The findings highlight a mechanistic basis for improved immunotherapy responses in solid tumor models, with implications for optimizing epigenetic modulation strategies in cancer research.

• Caspase-3 Fluorometric Assay Kit: Precision Apoptosis Detect

  2026-07-02

  The Caspase-3 Fluorometric Assay Kit delivers quantitative, DEVD-dependent detection of caspase-3 activity, a cysteine-dependent aspartate-directed protease central to apoptosis. Its one-step protocol enables sensitive measurement in diverse biological contexts, supporting robust apoptosis assay workflows.

• Etoposide (VP-16): Advanced Applications in Senescence Resea

  2026-07-01

  Explore how Etoposide (VP-16) empowers next-generation cancer and aging research by enabling precise DNA damage assays and senescence modulation. This in-depth review unveils fresh applications, protocols, and mechanistic insights beyond standard oncology approaches.

• OTUD3 Stabilizes SLC7A11 to Drive Sunitinib Resistance in cc

  2026-07-01

  This article analyzes how OTUD3-mediated stabilization of SLC7A11 suppresses ferroptosis, promoting sunitinib resistance in clear cell renal cell carcinoma (ccRCC). The study employs biochemical and cell-based assays to elucidate the mechanism, offering insight into potential strategies for overcoming drug resistance via ferroptosis modulation.

• VE-822 ATR Inhibitor: Advanced Radiosensitization in Tumor M

  2026-06-30

  Explore the role of VE-822 as a potent ATR inhibitor in enhancing tumor radiosensitivity, focusing on experimental strategies in physiologically relevant 3D models. This article delivers unique insights for DNA damage response inhibition and cancer chemoradiotherapy research.

• PPP2R2A Loss Sensitizes Ovarian Cancer to Chk1 Inhibition

  2026-06-30

  This study demonstrates that low PPP2R2A expression increases replication stress and enhances the vulnerability of high-grade serous ovarian cancer (HGSOC) cells to Chk1 inhibition. The findings reveal PPP2R2A as a predictive biomarker for Chk1 inhibitor sensitivity and suggest a new avenue to overcome therapy resistance in HGSOC.

• Ibuprofen: Mechanistic Insight and Strategic Impact in Trans

  2026-06-29

  This thought-leadership article explores the evolving role of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) as a tool compound in colon cancer research and beyond. It provides mechanistic clarity on COX inhibition, apoptosis induction, and cell cycle arrest, critically assesses experimental workflows, and positions APExBIO's Ibuprofen as a benchmark for reproducibility and translational relevance. Drawing on recent literature, including protein-drug interaction studies, the article guides researchers on protocol optimization and competitive differentiation.

• Silybin Chemistry: Structural Advances in Milk Thistle Resea

  2026-06-29

  Křen et al.'s review dissects the chemical structure, stereochemistry, and derivatization strategies of silybin, the major flavonolignan in milk thistle extract. These insights underpin improved research protocols in oxidative stress, cancer, and metabolic regulation, informing both experimental design and compound selection.

• Cyclosporin A: Mechanism, Applications, and Workflow in Rese

  2026-06-28

  Cyclosporin A is a potent cyclophilin inhibitor used for immunosuppression, apoptosis, and viral entry research. Its well-characterized mechanism and reproducible performance make it essential for modeling autoimmune and mitochondrial functions. This article details its biochemistry, protocol integration, and experimental boundaries.

• Enhancing Luteolin Bioavailability via P-gp Inhibition with

  2026-06-27

  This study introduces a novel self-microemulsifying drug delivery system (SME) loaded with luteolin, demonstrating a 29-fold increase in oral bioavailability by inhibiting P-glycoprotein (P-gp) efflux. The work provides a methodologically rigorous approach to overcoming absorption barriers for bioactive flavonoids, with direct implications for improving the pharmacokinetics of poorly soluble compounds.

• Bufalin as a Molecular Glue: Advanced Insights for Cancer Re

  2026-06-26

  Explore Bufalin, a cardiotonic steroid, as an advanced apoptosis inducer and molecular glue degrader in cancer research. This article offers a deep scientific analysis of its mechanisms, with a unique focus on practical assay implementation and the latest findings on STK33 targeting.

• Breast Cancer’s Dependence on MCL-1: Apoptotic Function Reve

  2026-06-26

  The referenced study clarifies that breast cancer cells’ reliance on MCL-1 stems from its canonical anti-apoptotic function rather than non-apoptotic roles. This distinction has significant impact on the design and application of selective MCL-1 inhibitors in cancer research, particularly for strategies aiming to induce apoptosis in MCL-1-dependent tumors.

• Caspase-8 Assays: Mechanistic Insight and Translational Leve

  2026-06-25

  This thought-leadership article integrates emerging mechanistic discoveries on caspase-8 in apoptosis and pyroptosis with strategic assay guidance for translational researchers. It contextualizes the Caspase-8 Fluorometric Assay Kit within the evolving landscape of programmed cell death research, referencing recent evidence and comparing assay solutions, while offering a forward-looking perspective on clinical and experimental implications.

13855 records 1/924 page Next 12345 下5页 Last page